Dr. Triche is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4650 W Sunset Blvd
Los Angeles, CA 90027Phone+1 323-361-3550Fax+1 323-361-8052
Summary
- Dr. Timothy Triche is a pathologist in Los Angeles, CA and is affiliated with Children's Hospital Los Angeles. He received his medical degree from Tulane University School of Medicine and has been in practice 46 years. He specializes in anatomic pathology, clinical pathology, and pediatric pathology.
Education & Training
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 1974 - 1975
- Barnes-Jewish Hosp Wash USurgical Pathology, 1973 - 1974
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1971 - 1973
- Tulane University School of MedicineClass of 1971
Certifications & Licensure
- CA State Medical License 1988 - 2025
- MD State Medical License 1988 - 2017
- LA State Medical License 1971 - 1978
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPrevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay.Trevor A Burrow, Balakrishna Koneru, Shawn J Macha, Wenyue Sun, Frederic G Barr
Frontiers in Oncology. 2024-01-01 - 3 citationsMitochondrial DNA haplogroup, genetic ancestry, and susceptibility to Ewing sarcoma.Kristiyana Kaneva, Theodore G Schurr, Tatiana V Tatarinova, Jonathan Buckley, Daria Merkurjev
Mitochondrion. 2022-11-01 - 4 citationsIntegrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma.Aaron M Taylor, Jiayi M Sun, Alexander Yu, Horatiu Voicu, Jianhe Shen
International Journal of Molecular Sciences. 2022-07-21
Press Mentions
- A More Targeted Approach in Pediatric Cancer Therapy?August 18th, 2021
- NanoValent Appoints Timothy Enns as Chief Executive OfficerJanuary 10th, 2017
- Children’s Hospital Los Angeles Announces Development of Unique Next Generation Sequencing-Based Panel Designed for Pediatric Cancer ResearchFebruary 18th, 2016
- Join now to see all
Grant Support
- Translation Of Predictive Cancer Biomarkers Into Clinical PracticeNational Cancer Institute2009–2010
- Microarray Core FacilityNational Cancer Institute2006–2010
- Diagnostic And Prognostic Sarcoma SignaturesNational Cancer Institute2005–2009
- Gene Expression In Sarcomas Of Childhood And AdolescenceNational Cancer Institute2000–2004
- Core--MicroarrayNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: